DIAMPA LT 25+5MG TAB

DIAMPA LT 25+5MG is a combination tablet containing Empagliflozin 25mg and Linagliptin 5mg, designed to help manage type 2 diabetes mellitus. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion by inhibiting DPP-4 enzyme. This dual-action formulation helps improve blood sugar control and may reduce cardiovascular risk. Suitable for patients inadequately controlled on monotherapy. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.